Novi review

"From $88/mo" is a twelve-month commitment

Novi's semaglutide page is titled "from $88/mo." The grid underneath it explains what that means, if you read the row labels: 1 month, $149. 3 months, $130/mo. 6 months, $129/mo. 12 months, $88/mo. Only the first of those is a monthly price. The rest are term prices divided by their terms — the number you'd get if you paid for a year and then did the division yourself.

The tirzepatide page runs the same shape: 1 month, $179. 3 months, $149/mo. 6 months, $133/mo. 12 months, $129/mo — titled "from $129/mo." So on both pages, the figure in the title is the one that requires the longest commitment, and the figure a month-to-month buyer actually pays is the one at the top of the grid. $149 and $179 are the numbers we headline, because they are the only two a monthly budget can use.

• Semaglutide, month to month: $149
• Semaglutide, prepay ladder: $130/mo over 3 months, $129/mo over 6, $88/mo over 12
• Tirzepatide, month to month: $179
• Tirzepatide, prepay ladder: $149/mo over 3 months, $133/mo over 6, $129/mo over 12
• Page titles: "from $88/mo" and "from $129/mo" — both twelve-month figures

None of that is hidden, exactly. It is simply arranged so the cheapest arithmetic sits in the title tag and the price you would actually be charged monthly sits in a row you have to look for. A mother comparing tabs sees $88 against another provider's monthly rate and draws a conclusion the page never quite said.

The homepage and the intake quote different numbers again

The homepage does not use either product page's grid. It runs "Was $299 / Now starting at $133/mo" beside a countdown claiming the price rises within 24 hours, on a page whose title tag literally reads "Summer Promo." That $133 is not a monthly rate anywhere on the site — on the tirzepatide page it is the six-month prepay figure. Alongside it the homepage promises "Same price, every dose," which is one of the claims here that does hold up.

The third surface is the one that matters at the register: Novi's intake flow serves a different, higher price variant than the public pages. So the number you compared, the number in the page title, and the number your card is charged can all be different — and only the last one is binding. Ask for it in writing before you enter a card, and check the amount against the page you shopped from.

Can you cancel? Novi answers both ways

This is the contradiction to settle before you pay, and it is not a matter of tone. Novi's Terms of Service, section VII.a: the first month's fee "as well as the monthly fee for the following two months (for a total of three (3) consecutive months) is charged at the time of purchase and is non-refundable," and "Subscription based Products and/or Services require a minimum 3-month commitment." The same clause warns that customers who dispute charges to escape that commitment "will be sent to collections" and may face further legal action. Cancellation requires 15 days' notice *and* that the three months have already concluded.

Novi's own help center, article title "Are there any long term contracts with Novi?", answers: "No. Your Novi membership operates on a monthly basis, and you can cancel at any time… there are no long-term contracts or commitments." Every marketing page badges "No hidden fees · No monthly membership · Cancel anytime." Meanwhile the attestation you tick at checkout says cancellation fees may apply and that multi-month packages are not refunded for unused medication or remaining months.

The Terms are the document you legally agree to. The help center is not. That asymmetry is the whole reason to read exit terms before paying rather than after — see our guide to stopping and restarting a GLP-1. Four separate refund policies exist across four Novi documents, and none is reconciled with the others. Two money-back guarantees are advertised: the "Novi Progress Promise," footnoted "see our terms of service for full details" — where the phrase appears zero times — and a differently-conditioned "Weight Loss Guarantee" described only in the help center.

The maternal screening is real, and better than most

Here Novi earns genuine credit, and it is the split worth knowing. On every public marketing and legal page, the words pregnancy, breastfeeding, nursing, postpartum, lactation and PCOS appear zero times. But inside the intake sits a screen titled "Safety, first." that asks whether any of the following apply: currently or possibly pregnant, or actively trying to conceive; breastfeeding or bottle-feeding with breastmilk; and — the one almost nobody asks — having given birth to a child within the last six months.

Only "None of the below" advances the form, and the three flagged options carry no forward action, which is consistent with a hard stop. We did not complete the intake, so we did not see what a flagged answer produces and will not tell you. What we can say is that the question is asked, specifically, and that most GLP-1 intakes we walk do not ask it. If you are still nursing, our breastfeeding evidence review is the place to start on timing.

What holds up, and one billing detail worth your calendar

Several claims survived checking. There is no separate program fee — the Terms fold a $20 physician consultation fee into the monthly price rather than adding it on top. Shipping is free, with cold packs. Pricing is flat across doses: "your payment stays the same regardless of dosage." Clinician messaging and visits are unlimited, seven days a week. And the compounding disclaimer on /compounded-semaglutide is accurate and unhedged — the FDA has not evaluated these medications for safety, quality or efficacy, and Novi says so.

One thing to put in your calendar rather than your budget: three billing intervals are on record. The Terms say every 30 days, the help center says every 28, and the help center's own payment schedule puts the second charge 21 days after the first, then every 28 days after that. At 28-day intervals that is roughly 13 charges a year, not 12.

Where the evidence sits

Confidence: low, and the reason is specific rather than general. Novi publishes a great deal — this is not a thin site. It is that the homepage, the product pages and the intake flow give three different answers about price, and that the single question a buyer most needs answered has two official answers from the same company. The compounding pharmacy is not named (no 503A, 503B or "outsourcing facility" anywhere), no clinician is named, /about returns a 404, and three different legal entity names appear across Novi's own Terms, Privacy Policy and Medical Consent. Its Notice of Privacy Practices even directs readers to a different company's domain — template reuse in a shared intake platform, recorded here as a documentation defect and nothing more. Novi carries no FDA warning letter; the database returns zero for it, and it is named in none of the 2025–2026 compounding waves. What would change this rating is one email: a written confirmation of your monthly amount, your commitment length and your charge dates. Get it before you pay. For a program whose price, billing date and exit terms all say the same thing, CoreAge Rx is the contrast. Our weighting is published at scoring methodology.